Ubiquoss (Korea) Performance
| 264450 Stock | 8,180 230.00 2.89% |
The entity has a beta of 0.13, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Ubiquoss' returns are expected to increase less than the market. However, during the bear market, the loss of holding Ubiquoss is expected to be smaller as well. At this point, Ubiquoss has a negative expected return of -0.0496%. Please make sure to validate Ubiquoss' standard deviation, total risk alpha, and the relationship between the coefficient of variation and jensen alpha , to decide if Ubiquoss performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Ubiquoss has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Ubiquoss is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Total Cashflows From Investing Activities | -22.9 B |
Ubiquoss |
Ubiquoss Relative Risk vs. Return Landscape
If you would invest 851,334 in Ubiquoss on September 27, 2024 and sell it today you would lose (33,334) from holding Ubiquoss or give up 3.92% of portfolio value over 90 days. Ubiquoss is generating negative expected returns and assumes 1.7901% volatility on return distribution over the 90 days horizon. Simply put, 15% of stocks are less volatile than Ubiquoss, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Ubiquoss Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ubiquoss' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Ubiquoss, and traders can use it to determine the average amount a Ubiquoss' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0277
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 264450 |
Estimated Market Risk
| 1.79 actual daily | 15 85% of assets are more volatile |
Expected Return
| -0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Ubiquoss is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ubiquoss by adding Ubiquoss to a well-diversified portfolio.
Ubiquoss Fundamentals Growth
Ubiquoss Stock prices reflect investors' perceptions of the future prospects and financial health of Ubiquoss, and Ubiquoss fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Ubiquoss Stock performance.
| Return On Equity | 18.27 | |||
| Return On Asset | 0.1 | |||
| Profit Margin | 0.17 % | |||
| Operating Margin | 0.19 % | |||
| Current Valuation | 158.56 B | |||
| Shares Outstanding | 5.12 M | |||
| Price To Sales | 0.96 X | |||
| Revenue | 139.09 B | |||
| EBITDA | 24.05 B | |||
| Cash And Equivalents | 30.08 B | |||
| Total Debt | 81.71 M | |||
| Cash Flow From Operations | 20.22 B | |||
| Total Asset | 168.01 B | |||
About Ubiquoss Performance
By analyzing Ubiquoss' fundamental ratios, stakeholders can gain valuable insights into Ubiquoss' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Ubiquoss has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Ubiquoss has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about Ubiquoss performance evaluation
Checking the ongoing alerts about Ubiquoss for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Ubiquoss help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Ubiquoss generated a negative expected return over the last 90 days | |
| About 41.0% of the company shares are owned by insiders or employees |
- Analyzing Ubiquoss' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Ubiquoss' stock is overvalued or undervalued compared to its peers.
- Examining Ubiquoss' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Ubiquoss' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Ubiquoss' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Ubiquoss' stock. These opinions can provide insight into Ubiquoss' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Ubiquoss Stock analysis
When running Ubiquoss' price analysis, check to measure Ubiquoss' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ubiquoss is operating at the current time. Most of Ubiquoss' value examination focuses on studying past and present price action to predict the probability of Ubiquoss' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ubiquoss' price. Additionally, you may evaluate how the addition of Ubiquoss to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |